Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Cryoport (CYRX) over the last 10 years, with Q2 2024 value amounting to $63.8 million.

  • Cryoport's Asset Writedowns and Impairment changed N/A to $63.8 million in Q2 2024 from the same period last year, while for Dec 2024 it was $64.0 million, marking a year-over-year change of. This contributed to the annual value of $63.8 million for FY2024, which is 2872.76% up from last year.
  • As of Q2 2024, Cryoport's Asset Writedowns and Impairment stood at $63.8 million.
  • Cryoport's 5-year Asset Writedowns and Impairment high stood at $63.8 million for Q2 2024, and its period low was -$237000.0 during Q4 2021.
  • In the last 4 years, Cryoport's Asset Writedowns and Impairment had a median value of $31000.0 in 2022 and averaged $4.9 million.
  • As far as peak fluctuations go, Cryoport's Asset Writedowns and Impairment surged by 15657058.82% in 2020, and later tumbled by 27819.55% in 2021.
  • Over the past 4 years, Cryoport's Asset Writedowns and Impairment (Quarter) stood at $133000.0 in 2020, then tumbled by 278.2% to -$237000.0 in 2021, then skyrocketed by 193.25% to $221000.0 in 2022, then soared by 28772.85% to $63.8 million in 2024.
  • Its last three reported values are $63.8 million in Q2 2024, $221000.0 for Q4 2022, and -$22000.0 during Q3 2022.